| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 07 Feb 2025 | SALE | NeuroVive Pharmaceutical AB | 2,493,402 | 0.45 SEK | |
| 03 May 2024 | PURCHASE | NeuroVive Pharmaceutical AB | 2,118,750 | 0.16 SEK | first after silence |
| 25 Jul 2022 | PURCHASE | NeuroVive Pharmaceutical AB | 42,724 | 0.35 SEK | |
| 25 Jul 2022 | PURCHASE | NeuroVive Pharmaceutical AB | 214,428 | 0.35 SEK | |
| 27 Sept 2021 | PURCHASE | NeuroVive Pharmaceutical AB | 117,500 | 0.09 USD |
1 purchase reported after at least 12 months of silence — most recent on 03 May 2024.